The Nanobody Market Data provides key insights into therapeutic adoption, clinical pipeline status, and regional distribution. Data shows oncology as the dominant segment, followed by autoimmune and infectious disease applications. Geographic analysis indicates North America holds the largest market share, driven by advanced biotechnology infrastructure and active clinical research....